Nov 9 (Reuters) - Biomx Inc PHGE.A :
* BIOMX REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
* BIOMX INC - CASH RUNWAY THROUGH AT LEAST MID-2024
* BIOMX INC - QTRLY LOSS PER SHARE $0.23
* BIOMX INC - CONTINUED PROGRESS ENROLLING PATIENTS IN PHASE
1/2
TRIAL OF BX004 FOR TREATMENT OF LUNG INFECTIONS IN CYSTIC
FIBROSIS
* BIOMX INC - RESULTS FROM PART 1 OF PHASE 1/2 TRIAL OF
BX004 NOW
EXPECTED IN Q1 2023
Source text for Eikon: ID:nGNX8gs4WG
Further company coverage: PHGE.A
((Reuters.Briefs@thomsonreuters.com;))